Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
POLYMEDIX, INC (PYMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/01/2013 8-K Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation unde...
03/21/2013 8-K Quarterly results
03/15/2013 8-K Material Modifications to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statemen...
Docs: "Certificate of Amendment to Amended and Restated Certificate of Incorporation PolyMedix, Inc",
"PolyMedix Announces Results of Special Meeting, Effective Date of Reverse Stock Split"
03/07/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/23/2013 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PolyMedix Engages Investment Banker, Amends Credit Facility"
11/09/2012 8-K Quarterly results
Docs: "PolyMedix Reports Third Quarter 2012 Financial Results"
08/09/2012 8-K Quarterly results
Docs: "PolyMedix Reports Second Quarter 2012 Financial Results"
06/12/2012 8-K Form 8-K - Current report
05/04/2012 8-K Submission of Matters to a Vote of Security Holders
04/23/2012 8-K Investor presentation
Docs: "PolyMedix Announces Positive Results from Phase 2 Clinical Trial with PMX-30063 First-in-Class Defensin-Mimetic Antibiotic Study in patients with Acute Bacterial Skin and Skin Structure Infections showed all three doses to have high clinical response rates and to be safe Conference Call Today at 9:00 a.m. ET",
"Webcast presentation"
04/10/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Loan and Security Agreement by and among PolyMedix, Inc., PolyMedix Pharmaceuticals, Inc., MidCap Financial SBIC, LP, as administrative agent, and the lenders listed thereto from time to time",
"Warrant to Purchase Common Stock",
"Registration Rights Agreement by and between PolyMedix, Inc. and MidCap Financial SBIC, LP",
"PolyMedix Restructures its Debt and Secures $12 Million Credit Facility"
04/10/2012 8-K Form 8-K - Current report
11/15/2011 8-K Form 8-K - Current report
06/20/2011 8-K Form 8-K - Current report
04/29/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/06/2011 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Underwriting Agreement by and between PolyMedix, Inc. and Cowen and Company, LLC",
"Form of Series D Warrant",
"Opinion of Pepper Hamilton LLP",
"PolyMedix Prices $20 Million Underwritten Offering"
01/24/2011 8-K Form 8-K - Current report
06/14/2010 8-K Form 8-K - Current report
06/07/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "PolyMedix Successfully Completes Phase 1B Clinical Study To Reverse Low Molecular Weight Heparin with PMX-60056"
04/02/2010 8-K Form 8-K - Current report
03/02/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/21/2009 8-K Form 8-K - Current report
11/17/2009 8-K Form 8-K - Current report
10/28/2009 8-K Form 8-K - Current report
07/06/2009 8-K Form 8-K - Current report
05/22/2009 8-K Form 8-K -- Current report
05/15/2009 8-K Form 8-K -- Current report
03/11/2009 8-K Form 8-K -- Current report
12/12/2008 8-K Form 8-K -- Current report
12/10/2008 8-K Form 8-K -- Current report
12/04/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "POLYMEDIX APPOINTS NEW VICE PRESIDENT OF BUSINESS DEVELOPMENT"
09/24/2008 8-K Form 8-K -- Current report
09/23/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Anticoagulant Antagonist Compound"
08/21/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Systemic Antibiotic Compound"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy